《异动股》恒发光学(01134.HK)续涨21%屡破顶 最近15个交易日累飙2倍
恒发光学(01134.HK)由11月13日收市价0.57元开始发力,15个交易日仅1天平收余下均升,本周二股价更突破首挂日盘中所造高位1.32元,今天高见1.72元,现造1.67元,续涨21%,较上月13日收市价更累飙1.9倍;一向薄弱成交倍增至431万股。
恒发光学是一间着名中港眼镜制造商,主要通过ODM及OEM业务模式生产及销售多种光学眼镜架及太阳眼镜。股份於去年7月中旬以每股1元上市,净筹8,070万元,主要用作提高产能、还债、提升设计与开发能力及推广等。上市独家保荐人信达国际。
受累於新冠肺炎大疫情大流行,该公司今年上半年业绩扭盈转蚀825.7万元。此外,公司上月公布,为减轻疫情的不利影响及维持稳健财务状况,集团决定暂时搁置扩大集团於江西产能及减少推广等,将上市集资所得未动用款项2,000万元重新分配为集团一般营运资金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.